Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Low colon cancer screening rates leaves a million New Yorkers at risk

25.07.2005


Half of New York City residents over 50, the age at which the American Cancer Society recommends beginning screening tests, have not received a colon cancer-screening test within the recommended time intervals, according to a new study. The report, published in the September 1, 2005 issue of CANCER, a peer-reviewed journal of the American Cancer Society, says those New Yorkers least likely to have received screening include those with low-income, the uninsured, Asians and current smokers.



More than 56,000 Americans are expected to die this year from colorectal cancer, making it the third leading cause of cancer death in both men and women. Screening tests, which include the fecal occult blood test (FOBT), flexible sigmoidoscopy (FS), and colonoscopy, have been proven to reduce mortality and be more cost-effective than breast cancer screening tests, which are more widely used. Current screening guidelines recommend annual FOBT, FS every 5 years, or a colonoscopy every 10 years, but only 53 percent of Americans receive timely screening.

New York City is unique in that there is high density of gastroenterologists and endoscopy labs to provide access to colonoscopy services. In 2003, the city adopted new screening guidelines--a colonoscopy every 10 years or FOBT every year as an acceptable, although not optimal, alternative for those unwilling or unable to undergo colonoscopy. To evaluate the effect of this change, Lorna Thorpe, Ph.D. of the New York City Department of Health and Mental Hygiene and researchers from leading hospitals and academic institutions conducted a baseline telephone survey of the colon cancer screening habits of 9,802 New York City residents.


Only 55 percent of the 3606 New York City adults age 50 and older reported a recent colorectal cancer screening test within the time interval recommended by national guidelines. Forty-two percent of those received a colonoscopy, while 32 percent received a FOBT and 10 percent received FS, respectively.

Analysis showed that men were more likely than women to have received either colonoscopy or FS. Also, men age 65 and older were significantly more likely to have a colonoscopy than younger men. Non-Hispanic African-Americans and women were less likely to receive colonoscopies, having higher rates of FOBT use instead. The lower uptake of colonoscopy among non-Hispanic African-Americans was of particular concern, given the high rates of colon cancer mortality in this population in New York City. Asians--women in particular--were the racial group least likely to have undergone a timely screening test. In addition, smoking, low-income and lack of health insurance were each associated with a decreased likelihood of having had a recent screening test. In contrast, those who utilized preventive care, such as receiving annual flu shots, were more likely to have a screening test within the recommended time interval.

Dr. Thorpe and her colleagues conclude, "nearly half of New Yorkers ages 50 and older are not undergoing screening within the recommended schedule." They add, "Resources and interventions designed to increase screening practices, particularly colonoscopy, will need to target poor and uninsured communities."

Amy Molnar | EurekAlert!
Further information:
http://www.wiley.com

More articles from Health and Medicine:

nachricht GLUT5 fluorescent probe fingerprints cancer cells
20.04.2018 | Michigan Technological University

nachricht Scientists re-create brain neurons to study obesity and personalize treatment
20.04.2018 | Cedars-Sinai Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

Im Focus: Like a wedge in a hinge

Researchers lay groundwork to tailor drugs for new targets in cancer therapy

In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Magnetic nano-imaging on a table top

20.04.2018 | Physics and Astronomy

Start of work for the world's largest electric truck

20.04.2018 | Interdisciplinary Research

Atoms may hum a tune from grand cosmic symphony

20.04.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>